Vivos (RDGL) Revenue Growth (3y) (2014 - 2025)
Vivos (RDGL) Revenue Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 8.05% |
| 10 | Vivos | 22.64 Mn | 21.08 Mn | -3,105.00 | 56.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.17% |
| Sep 30, 2025 | -33.88% |
| Jun 30, 2025 | 12.62% |
| Mar 31, 2025 | 27.19% |
| Sep 30, 2024 | -30.49% |
| Sep 30, 2023 | 0.00% |
| Dec 31, 2022 | 63.02% |
| Sep 30, 2022 | -6.69% |
| Sep 30, 2019 | 25.43% |
| Mar 31, 2017 | -33.93% |
| Sep 30, 2016 | -67.29% |
| Mar 31, 2016 | -45.33% |
| Sep 30, 2015 | -43.05% |
| Mar 31, 2015 | -43.67% |
| Jun 30, 2014 | -58.43% |
| Mar 31, 2014 | -54.64% |